Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Study of Cetuximab, Oxaliplatin, 5-FU/LV Versus Oxaliplatin, 5-FU/LV in Patients With Previously Treated Metastatic, EGFR-Positive Colorectal Cancer

ClinicalTrials.gov ID: NCT00061815

Public ClinicalTrials.gov record NCT00061815. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 27, 2026, 7:18 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Randomized Multicenter Study of Cetuximab, Oxaliplatin, 5-Fluorouracil, and Leucovorin vs. Oxaliplatin, 5-Fluorouracil, and Leucovorin in Subjects With Previously Treated Metastatic, EGFR-Positive Colorectal Carcinoma

Study identification

NCT ID
NCT00061815
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
102 participants

Conditions and interventions

Interventions

  • cetuximab Biological
  • oxaliplatin Drug
  • leucovorin Drug
  • 5-fluorouracil Drug

Biological · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2003
Primary completion
Nov 30, 2004
Completion
Oct 31, 2005
Last update posted
Apr 11, 2010

2003 – 2005

United States locations

U.S. sites
39
U.S. states
19
U.S. cities
39
Facility City State ZIP Site status
ImClone Investigational Site Little Rock Arkansas 72205
ImClone Investigational Site Springdale Arkansas 72764
ImClone Investigational Site Fountain Valley California 92708
ImClone Investigational Site Gilroy California 95020
ImClone Investigational Site Greenbrae California 94904
ImClone Investigational Site Orange California 92868
ImClone Investigational Site Pomona California 91767
ImClone Investigational Site San Diego California 92120
ImClone Investigational Site Vista California 92083
ImClone Investigational Site Hartford Connecticut 06105
ImClone Investigational Site Norwalk Connecticut 06856
ImClone Investigational Site Stamford Connecticut 06902
ImClone Investigational Site Waterbury Connecticut 06708
ImClone Investigational Site Boynton Beach Florida 33435
ImClone Investigational Site Jacksonville Florida 32207
ImClone Investigational Site Leesburg Florida 34748
ImClone Investigational Site Orlando Florida 32804
ImClone Investigational Site Tampa Florida 33613
ImClone Investigational Site Atlanta Georgia 30309
ImClone Investigational Site Macon Georgia 31201
ImClone Investigational Site Louisville Kentucky 40202
ImClone Investigational Site Baton Rouge Louisiana 70809
ImClone Investigational Site Baltimore Maryland 21225
ImClone Investigational Site Clinton Maryland 20735
ImClone Investigational Site Saint Joseph Michigan 49085
ImClone Investigational Site Kansas City Missouri 64131
ImClone Investigational Site Rolla Missouri 65401
ImClone Investigational Site Hackensack New Jersey 07601
ImClone Investigational Site Armonk New York 10504
ImClone Investigational Site Brooklyn New York 11235
ImClone Investigational Site East Setauket New York 11733
ImClone Investigational Site Winston-Salem North Carolina 27103
ImClone Investigational Site Bismarck North Dakota 58501
ImClone Investigational Site Philadelphia Pennsylvania 19107
ImClone Investigational Site Charleston South Carolina 29406
ImClone Investigational Site Knoxville Tennessee 37920
ImClone Investigational Site Nashville Tennessee 37203
ImClone Investigational Site Ogden Utah 84403
ImClone Investigational Site Richmond Virginia 23230

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00061815, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 11, 2010 · Synced Jun 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00061815 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →